A phase I study of tasisulam sodium (LY573636 sodium), a...

Cancer Chemotherapy and Pharmacology 2011 / 11 Vol. 68; Iss. 5

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

George R. Simon, Robert L. Ilaria, Mika A. Sovak, Charles C. Williams, Eric B. Haura, Ann L. Cleverly, Amanda K. Sykes, Margaret M. Wagner, Dinesh P. de Alwis, Christopher A. Slapak, Mary A. Miller, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
68
Language:
english
Pages:
9
DOI:
10.1007/s00280-011-1593-0
Date:
November, 2011
File:
PDF, 1.75 MB
english, 2011
Conversion to is in progress
Conversion to is failed